The COVID-19 pandemic constitutes an arduous global health challenge, and the
increasing number of fatalities calls for the speedy pursuit of a remedy. This review …

To address the COVID-19 pandemic, there has been an unprecedented global effort to
advance potent neutralizing mAbs against SARS-CoV-2 as therapeutics. However, historical …

Abstract Coronavirus disease-2019 (COVID-19) is asymptomatic in most cases, but it is
impartible and fatal in fragile and elderly people. Heretofore, more than four million people …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19). About 45% of COVID-19 patients experience several symptoms a …

Background Our understanding of coronavirus disease 2019 (COVID-19) and its
implications for patients with inflammatory bowel diseases (IBD) is rapidly evolving. We …

The devastating pandemic of coronavirus disease 2019 (COVID-19) has caused thousands
of deaths and left millions of restless patients suffering from its complications. Increasing …

The novel beta coronavirus (SARS-CoV-2, designated as COVID-19) that is responsible for
severe acute respiratory syndrome has devastated the global economy and health care …

Rapid detection methods for cytokine storm markers, such as tumor necrosis factor α (TNF-α)
and interferon gamma (IFN-γ), are required. Herein, we describe the fabrication of a rapid …

Abstract Background and Aims Patients with severe coronavirus disease 2019 (COVID‐19)
are at significant risk of thrombotic complications. However, their prothrombotic state is …

COVID-19 remains a global pandemic of an unprecedented magnitude with millions of
people now developing “COVID lung fibrosis.” Single-cell transcriptomics of lungs of patients …